ArticleThe Pan African medical journal2025
Stroke risk assessment in children with sickle cell disease using transcranial Doppler ultrasound in Cameroon.
Article in The Pan African medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Stroke is a severe complication of sickle cell disease, often resulting from cerebral vasculopathy. Transcranial Doppler Ultrasound is a validated tool for stroke risk prediction in sickle cell disease, enabling timely preventive interventions. This study assessed cerebral vasculopathy in children with sickle cell disease using transcranial Doppler in three hospitals in Cameroon. Methods: a cross-sectional study was conducted from January to April 2024 in Buea, Limbe, and Laquintinie Hospitals. Children aged 2-16 years with confirmed sickle cell disease were evaluated. Data on demographics, clinical history, immunization status, hematological parameters, and cerebral blood flow velocities (time-averaged mean maximum velocity and peak systolic velocity in the middle cerebral and distal internal carotid arteries) were collected. Stroke risk was classified per the stroke prevention trial for sickle cell anemia (STOP) trial criteria. Statistical analysis included descriptive, bivariate, and multivariate methods (SPSS v23.0), with significance set at p<0.05. Results: among 110 participants (mean age 8.35 ± 3.74 years), 79.1% had normal arterial velocities, 12.7% intermediate, and 8.2% high velocities, indicating elevated stroke risk. Acute chest infections could be significantly associated with high velocities, while prophylactic vaccination (meningococcal and pneumococcal) could be protective. Conclusion: approximately 8.2% of children with sickle cell disease showed high cerebral artery velocities, suggesting high stroke risk. Acute chest infections may exacerbate this risk, whereas vaccination could appear protective. Transcranial Doppler is a valuable tool for early stroke risk stratification in pediatric sickle cell disease populations in resource-limited settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.